| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Boulevard Acquisition Corp. II (TBA) (u) | Citigroup | 35.00 | $10.00 | $10.00 | $350.00 | n.a. |
| CPI Card Group (TBA) | BMO Capital Markets/ Goldman Sachs/ CIBC | $100.00 | n.a. | |||
| Mauser Group N.V. (TBA) | BofA Merrill Lynch/ Citi/ Credit Suisse | $100.00 | n.a. | |||
| Neiman Marcus Group (TBA) | TBA | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Benitec Biopharma LTD (BNTC) | BMO Capital Markets/ Maxim Group LLC | $20.00 | N/C | |||
| Philadelphia Energy Solutions (PESC) | BofA Merrill Lynch/ Credit Suisse | 15.15 | $15.00 | $18.00 | $250.00 | 1-Star |
| RiverBanc Multifamily Investors (RMI) | Baird/ Keefe, Bruyette & Woods (A Stifel Company)/ SunTrust Robinson Humphrey | 3.80 | $19.00 | $20.00 | $74.10 | 1-Star |
| N/C = No Call -stock is traded on the Australian Securities Exchange since 1997 | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Boxlight (BOXL) | Aegis Capital Corp | 1.82 | $10.00 | $12.00 | $20.00 | 1-Star |
| Houlihan Lokey (HLI) | BofA Merrill Lynch/ Goldman Sachs | 13.06 | $22.00 | $24.00 | $300.36 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Aug. 3, 2015 | Manager(s) | Offered | Raised | Price | 8/7/15 | Change |
| Zynerba Pharmeceuticals (ZYNE) | Jefferies/ Piper Jaffray | 3.00 | $42.00 | $14.00 | $24.54 | 75.29% |
| Aimmune Therapeutics (AIMT) | BofA Merrill Lynch/ Credit Suisse/ Piper Jaffray | 10.00 | $160.00 | $16.00 | $23.00 | 43.75% |
| Planet Fitness (PLNT) | J.P. Morgan Securities Merrill Lynch/ Jefferies/ Credit Suisse Securities | 13.50 | $216.00 | $16.00 | $18.25 | 14.06% |
| Intec Pharma Ltd. (NTEC) | Maxim Group/ Roth Capital Partners | 6.00 | $36.00 | $6.00 | $5.99 | -0.17% |
| Amplify Snack Brands (BETR) | Goldman Sachs/ Jefferies/ Credit Suisse | 15.00 | $270.00 | $18.00 | $16.19 | -10.06% |
| Sunrun (RUN) | Credit Suisse/ Goldman Sachs/ Morgan Stanley | 17.90 | $250.60 | $14.00 | $10.14 | -27.57% |